We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002673:SZSEWestern Securities Co., Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥7.72

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Western Securities is trading at CNY 7.72, well below its DCF-derived fair value of CNY 50.88, suggesting a substantial upside potential. The stock sits just above the computed support level of CNY 7.54 and below the nearest resistance at CNY 8.00, with a bearish trend indicated by the 20‑day SMA (7.78) under the 50‑day SMA (7.93). Momentum indicators are mixed: RSI is near the midpoint at 44.5, while the MACD line has crossed above its signal, producing a bullish histogram slice. Volume remains stable, indicating sufficient liquidity for short‑term positioning.
Fundamentally, the company posted a robust 36.8% revenue growth and maintains high profitability margins (gross 64%, operating 40%, net 29%). Despite a low beta of 0.21, indicating limited market sensitivity, the firm carries a high debt‑to‑equity ratio (>150%) and modest ROE (6.7%). The dividend yield of 1.56% with a payout ratio of 23% appears sustainable given strong cash balances. These dynamics create a blend of growth appeal and value upside, tempered by regulatory and debt considerations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support with limited upside before hitting resistance
  • Mixed momentum signals (MACD bullish, RSI neutral)
  • Stable trading volume supporting liquidity

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation gap between market price and DCF fair value
  • Strong revenue growth and high profitability margins
  • Sustainable dividend yield enhancing total return

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt‑to‑equity ratio may constrain future capital allocation
  • Potential regulatory tightening in China's capital markets
  • Consistent dividend payout providing steady income

Key Metrics & Analysis

Financial Health

Revenue Growth36.80%
Profit Margin29.15%
P/E Ratio18.0
ROE6.67%
ROA1.88%
Debt/Equity156.58
P/B Ratio1.2
Op. Cash FlowCN¥7.4B
Industry P/E16.5

Technical Analysis

TrendBearish
RSI44.5
SupportCN¥7.54
ResistanceCN¥8.00
MA 20CN¥7.78
MA 50CN¥7.93
MA 200CN¥8.16
MACDBullish
VolumeStable
Fear & Greed Index79.55

Valuation

Fair ValueCN¥50.88
Target PriceCN¥8.80
Upside/Downside13.99%
GradeUndervalued
TypeBlend
Dividend Yield1.56%

Risk Assessment

Beta0.21
Volatility17.49%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.